Disposable Angiography Needlele segmentation by application isolates three dominant end‑use groups: cardiology, interventional radiology, and neurovascular procedures. Cardiology, which includes coronary angiography, peripheral arterial disease assessment, and structural heart interventions, represents the largest share at roughly 45 % of market revenue, reflecting the high procedural volume and routine reliance on angiographic imaging in cardiac catheterization labs. Interventional radiology, encompassing hepatic chemo‑embolization, tumor ablation guidance, and peripheral embolization, contributes about 35 % of the market; its growth is propelled by expanding minimally invasive oncology therapies and the need for precise vascular access. Neurovascular applications, such as cerebral aneurysm coiling and stroke thrombectomy, account for the remaining 20 % and are growing faster than the overall market due to increasing adoption of endovascular stroke treatment protocols. These application segments collectively define the market taxonomy and dictate the allocation of manufacturing capacity, pricing strategies, and R&D focus across the Disposable Angiography Needlele landscape.